Personalized therapies in the cancer "omics" era

por Ocaña, Alberto, Pandiella, Atanasio
Publicado 2010

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies

por Ocana, Alberto, Pandiella, Atanasio
Publicado 2017

Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer

por Manzano, Aranzazu, Ocaña, Alberto
Publicado 2020

Proteolysis targeting chimeras (PROTACs) in cancer therapy

por Ocaña, Alberto, Pandiella, Atanasio
Publicado 2020

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results

por Ocaña, Alberto, Amir, Eitan, Pandiella, Atanasio
Publicado 2018

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates

por Ocaña, Alberto, Amir, Eitan, Pandiella, Atanasio
Publicado 2020

Achilles' heel of triple negative cancer

por Ocaña, Alberto, Montero, Juan C., Pandiella, Atanasio
Publicado 2014

Achilles' heel of triple negative cancer

por Ocaña, Alberto, Montero, Juan C., Pandiella, Atanasio
Publicado 2014

Erratum: Achilles' heel of triple negative cancer

por Ocaña, Alberto, Montero, Juan C., Pandiella, Atanasio
Publicado 2014

BET inhibitors as novel therapeutic agents in breast cancer

por Ocaña, Alberto, Nieto-Jiménez, Cristina, Pandiella, Atanasio
Publicado 2017

Breast Cancer Heterogeneity and Response to Novel Therapeutics

por Baliu-Piqué, Mariona, Pandiella, Atanasio, Ocana, Alberto
Publicado 2020

Generation of Antibody-Drug Conjugate Resistant Models

por Gandullo-Sánchez, Lucía, Ocaña, Alberto, Pandiella, Atanasio
Publicado 2021

HER3 in cancer: from the bench to the bedside

por Gandullo-Sánchez, Lucía, Ocaña, Alberto, Pandiella, Atanasio
Publicado 2022

Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel

por Zist, Andrej, Amir, Eitan, Ocana, Alberto F., Seruga, Bostjan
Publicado 2015

Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling

por Montero, Juan Carlos, García-Alonso, Sara, Ocaña, Alberto, Pandiella, Atanasio
Publicado 2015

Neutrophils in cancer: prognostic role and therapeutic strategies

por Ocana, Alberto, Nieto-Jiménez, Cristina, Pandiella, Atanasio, Templeton, Arnoud J
Publicado 2017

Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs

por Díaz-Rodríguez, Elena, Gandullo-Sánchez, Lucía, Ocaña, Alberto, Pandiella, Atanasio
Publicado 2021

Clinical considerations for the design of PROTACs in cancer

por Nieto-Jiménez, Cristina, Morafraile, Esther Cabañas, Alonso-Moreno, Carlos, Ocaña, Alberto
Publicado 2022

Considerations for the clinical development of immuno-oncology agents in cancer

por Pandiella, Atanasio, Calvo, Emiliano, Moreno, Victor, Amir, Eitan, Templeton, Arnoud, Ocana, Alberto
Publicado 2023

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2

por Pandiella, Atanasio, Morís, Francisco, Ocaña, Alberto, Núñez, Luz-Elena, Montero, Juan C.
Publicado 2015